Predict your next investment

Venture Capital
bioventure.com.cn

See what CB Insights has to offer

Investments

109

Portfolio Exits

8

Funds

2

About bioVENTURE

Suzhou Industrial Park Bioventure Investment Management (苏州元生创投), dba bioVENTURE (元生创投), is an early-stage venture capital firm that focuses on life sciences.

bioVENTURE Headquarter Location

Suzhou Industrial Park 218 A1 Building 2 / F, North E37 Unit

Suzhou, Jiangsu, 215123,

China

+86 512 6288 6525

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing bioVENTURE

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find bioVENTURE in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Research containing bioVENTURE

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned bioVENTURE in 1 CB Insights research brief, most recently on Apr 29, 2021.

Latest bioVENTURE News

DealShot: 16 Deals Worth $275 Million Counting Bioventure, ZJ Innopark And Many More

Sep 17, 2021

All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.

bioVENTURE Investments

109 Investments

bioVENTURE has made 109 investments. Their latest investment was in Weisierkang as part of their Seed VC on September 9, 2021.

CBI Logo

bioVENTURE Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/17/2021

Seed VC

Weisierkang

Yes

2

9/16/2021

Series A - II

Reforgene

Yes

BioTrack Capital, China Everbright Limited, China Merchants Securities Asset Management, and Sinovation Ventures

6

9/14/2021

Series C

Union Strong

No

4

9/13/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

9/8/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/17/2021

9/16/2021

9/14/2021

9/13/2021

9/8/2021

Round

Seed VC

Series A - II

Series C

Seed VC

Seed VC - II

Company

Weisierkang

Reforgene

Union Strong

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

BioTrack Capital, China Everbright Limited, China Merchants Securities Asset Management, and Sinovation Ventures

Sources

2

6

4

10

10

bioVENTURE Portfolio Exits

8 Portfolio Exits

bioVENTURE has 8 portfolio exits. Their latest portfolio exit was NanoMicro Tech on June 23, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/23/2021

IPO

$991

2

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

6/23/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

IPO

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

$991

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

bioVENTURE Fund History

2 Fund Histories

bioVENTURE has 2 funds, including YuanBio Venture Capital LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/30/2018

YuanBio Venture Capital LP

Early-Stage Venture Capital

1

Suzhou Industrial Park Xinjianyuan Biological Venture Capital Fund II LP

Subscribe to see more

$99M

10

Closing Date

3/30/2018

Fund

YuanBio Venture Capital LP

Suzhou Industrial Park Xinjianyuan Biological Venture Capital Fund II LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Status

Amount

$99M

Sources

1

10

bioVENTURE Team

1 Team Member

bioVENTURE has 1 team member, including current Managing Partner, Jie Chen.

Name

Work History

Title

Status

Jie Chen

Managing Partner

Current

Name

Jie Chen

Work History

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.